NOVT logo

Novanta Inc. (NOVT)

$139.94

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on NOVT

Market cap

$5.29B

EPS

1.57

P/E ratio

89.9

Price to sales

5.19

Dividend yield

--

Beta

1.724332

Price on NOVT

Previous close

$135.59

Today's open

$137.73

Day's range

$137.43 - $141.19

52 week range

$98.27 - $176.38

Profile about NOVT

CEO

Matthijs Glastra

Employees

3000

Headquarters

Bedford, MA

Exchange

Nasdaq Global Select

Shares outstanding

37817770

Issue type

Common Stock

NOVT industries and sectors

Technology

Hardware & Equipment

News on NOVT

Human Data, Robot Hands: Where Automation Goes Next

High-quality real-world data has been a major bottleneck for teaching robot hands: A video can show movement without measuring touch or force.

news source

ETF Trends • Oct 21, 2026

news preview

Novanta to Present at the Baird 2026 Global Industrial Conference on Wednesday, November 11, 2026

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, and John Lesica, Chief Operating Officer of Medical Solutions, are scheduled to present at the Baird 2026 Global Industrial Conference on Wednesday, November 11, 2026, in Chicago, Illinois. About Novanta Novanta is a leading global supplier of core technology solutions that giv.

news source

Business Wire • Oct 20, 2026

news preview

How to Invest in AI Drug Discovery

.Danaher (DHR), one of the world's largest providers of medical diagnostics and laboratory equipment, recently announced plans to launch its first AI-powered autonomous laboratory, scheduled to operate at commercial scale in early 2027. While market trading barely moved the stock on the announcement date, the news marks a quiet turning point for life science automation.

news source

ETF Trends • Oct 14, 2026

news preview

Novanta Inc. Announces Schedule of Third Quarter 2026 Earnings Release and Conference Call

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2026 results after the close of U.S. financial markets on Monday, November 9, 2026. The Company will host a conference call on Tuesday, November 10, 2026 at 8:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conf.

news source

Business Wire • Oct 13, 2026

news preview

How to Build a Humanoid Body

Last month we broke down the three key areas needed to build your own humanoid. We have already looked at the companies behind the technologies required to build a humanoid's brain.

news source

ETF Trends • Sep 16, 2026

news preview

Are Robots the New Normal? Bet on these ETFs to Invest in the Future

Robotics is entering a new era as AI fuels humanoid adoption, with four ETFs offering diversified exposure to the sector's growth.

news source

Zacks Investment Research • Sep 4, 2026

news preview

Novanta to Present at Baird Global Healthcare Conference on Tuesday, September 15, 2026

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, and John Lesica, Chief Operating Officer of Medical Solutions, are scheduled to present at the Baird Global Healthcare Conference on Tuesday, September 15, 2026, in New York, NY. About Novanta Novanta is a leading global supplier of core technology solutions that give medical a.

news source

Business Wire • Aug 28, 2026

news preview

How to Build a Humanoid Brain

In our previous guide to building a humanoid robot, we mapped out the three essential pillars of the project: the brain, the body, and the energy systems. Now, it is time to look closer at the brain.

news source

ETF Trends • Aug 19, 2026

news preview

Recent Price Trend in Novanta (NOVT) is Your Friend, Here's Why

If you are looking for stocks that are well positioned to maintain their recent uptrend, Novanta (NOVT) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

news source

Zacks Investment Research • Aug 18, 2026

news preview

Are You Looking for a Top Momentum Pick? Why Novanta (NOVT) is a Great Choice

Does Novanta (NOVT) have what it takes to be a top stock pick for momentum investors? Let's find out.

news source

Zacks Investment Research • Aug 12, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Novanta Inc.

Open an M1 investment account to buy and sell Novanta Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in NOVT on M1